Kamada Ltd stock is traded at $6.87, with a volume of 257,657. It is down -7.41% in the last 24 hours and down -14.13% over the past month. Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Previous Close:
$7.42
Open:
$7.01
24h Volume:
257,657
Relative Volume:
2.02
Market Cap:
$396.47M
Revenue:
$181.68M
Net Income/Loss:
$20.37M
P/E Ratio:
19.66
EPS:
$0.3495
Net Cash Flow:
$17.31M
1W Performance:
-13.58%
1M Performance:
-14.13%
6M Performance:
-16.32%
1Y Performance:
-0.58%
1-Day Range:
$6.77$7.12
1-Week Range:
$6.77$7.57
52-Week Range:
$6.55$9.35
Kamada Ltd Stock (KMDA) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS